HomeCompareCRHKF vs GBDC

CRHKF vs GBDC: Dividend Comparison 2026

CRHKF yields 3.39% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CRHKF wins by $743.80M in total portfolio value· pulled ahead in Year 7
10 years
CRHKF
CRHKF
● Live price
3.39%
Share price
$3.51
Annual div
$0.12
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$764.57M
Annual income
$723,573,142.55
Full CRHKF calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — CRHKF vs GBDC

📍 CRHKF pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRHKFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRHKF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CRHKF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRHKF
Annual income on $10K today (after 15% tax)
$288.18/yr
After 10yr DRIP, annual income (after tax)
$615,037,171.17/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, CRHKF beats the other by $601,106,297.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRHKF + GBDC for your $10,000?

CRHKF: 50%GBDC: 50%
100% GBDC50/50100% CRHKF
Portfolio after 10yr
$392.67M
Annual income
$369,981,202.98/yr
Blended yield
94.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

CRHKF
No analyst data
Altman Z
3.1
Piotroski
6/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRHKF buys
0
GBDC buys
2
PoliticianChamberTickerTypeAmountDate
David P. Joyce🏢 House$GBDC▼ Sell$1,001 - $15,0002023-06-30
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002023-06-19
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-14
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-12
Teresa Leger Fernandez🏢 House$GBDC▼ Sell$15,001 - $50,0002021-01-20
David P. Joyce🏢 House$GBDC▲ Buy$1,001 - $15,0002020-02-25
David P. Joyce🏢 House$GBDC▲ Buy$15,001 - $50,0002019-05-30
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRHKFGBDC
Forward yield3.39%11.85%
Annual dividend / share$0.12$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%51.1%
Portfolio after 10y$764.57M$20.78M
Annual income after 10y$723,573,142.55$16,389,263.41
Total dividends collected$761.58M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: CRHKF vs GBDC ($10,000, DRIP)

YearCRHKF PortfolioCRHKF Income/yrGBDC PortfolioGBDC Income/yrGap
1$11,378$678.06$12,490$1,790.28$1.1KGBDC
2$13,617$1,442.06$16,522$3,157.73$2.9KGBDC
3$17,796$3,225.75$23,578$5,898.68$5.8KGBDC
4$26,921$7,879.86$37,115$11,886.75$10.2KGBDC
5$51,087$22,281.62$66,136$26,423.57$15.0KGBDC
6$133,697$79,033.74$137,257$66,491.44$3.6KGBDC
7← crossover$529,662$386,606.15$341,734$194,868.54+$187.9KCRHKF
8$3,429,546$2,862,807.29$1,050,788$685,133.02+$2.38MCRHKF
9$38,317,453$34,647,839.50$4,099,314$2,974,971.01+$34.22MCRHKF
10$764,572,818$723,573,142.55$20,775,530$16,389,263.41+$743.80MCRHKF

CRHKF vs GBDC: Complete Analysis 2026

CRHKFStock

China Resources Beer (Holdings) Company Limited, an investment holding company, manufactures, distributes, and sells beer products. The company offers its products under the Heineken, Li, Löwen Fruit Beer, Snow Xiao Pi Qi, Amstel, and Edelweiss brand names. As of March 24, 2022, it operated 65 breweries in 24 provinces, municipalities, and autonomous regions in Mainland China. The company also engages in the manufacture and distribution of Baijiu products; and development and management of real estate. The company was formerly known as China Resources Enterprise, Limited and changed its name to China Resources Beer (Holdings) Company Limited in October 2015. The company is based in Wan Chai, Hong Kong. China Resources Beer (Holdings) Company Limited is a subsidiary of China Resources (Holdings) Company Limited.

Full CRHKF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this CRHKF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRHKF vs SCHDCRHKF vs JEPICRHKF vs OCRHKF vs KOCRHKF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.